Healthcare

Introduction

Fondita Healthcare invests in shares of publicly traded companies whose activities promote health and well-being. The fund’s growth is driven by an aging population, increased prosperity (wealth and living standards), technological development, climate and environmental change and the healthcare sector’s low price-elasticity. 

Fondita Healthcare is an actively managed fund with approx. 30 holdings. The fund is primarily aimed at long-term investors. The fund avoids investments in loss-making biotechnology companies. 

The fund´s investment decisions take the environmental and social impacts of companies and governance into account, as well as risks related to this.

Fund facts

Fund size 72,6 MEUR
Fund unitholders 234
ISIN (A) FI4000321088
ISIN (B) FI4000321096
Legal structure UCITS
Currency EUR
Management fee 2,00 % p.a.
Risk profile 5/7

Top 5 Holdings

Siegfried Holding (CH) 6,1 %
Straumann (CH) 4,3 %
Astra Zeneca (GB) 4,2 %
Lonza Group (CH) 4,0 %
Carl Zeiss (DE) 3,8 %

Top 5 Countries

Switzerland 24 %
USA 22 %
Germany 17 %
Sweden 12 %
Denmark 12 %

Return

1 month 4,1 %
3 months 9,6 %
6 months 17,4 %
YTD 17,4 %
1 year 35,6 %
since launch (14.6.2018) 63,9 %
since launch p.a. 62,0 %
Portfolio managers

Sector Division

Health Care 96 %
Information Technology 2 %
Cash 1 %

Top 10 Holdings

Siegfried Holding (CH) 6,1 %
Straumann (CH) 4,3 %
Astra Zeneca (GB) 4,2 %
Lonza Group (CH) 4,0 %
Carl Zeiss (DE) 3,8 %
Smith & Nephew (GB) 3,8 %
Eli Lilly (US) 3,4 %
Medicover (SE) 3,4 %
Medtronic (US) 3,3 %
Siemens Healthineers (GB) 3,2 %

Country Division

Switzerland 24 %
USA 22 %
Germany 17 %
Sweden 12 %
Denmark 12 %
Finland 5 %
Great Britain 4 %
Netherlands 3 %
Spain 1 %

Currency Exposure

EUR 25 %
CHF 24 %
USD 22 %
SEK 12 %
DKK 12 %
GBP 4 %
The past performance of the investment fund does not provide any guarantee of future results. Depending on market conditions, the fund unit value may rise or fall.

Risk Profile

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Less risk
More risk
A high number means that the fund has a higher risk and that the value of the fund can vary greatly. This means that both return and risk potential is greater.

Return

1 month 4,1 %
3 months 9,6 %
6 months 17,4 %
YTD 17,4 %
1 year 35,6 %
since launch (14.6.2018) 63,9 %
since launch p.a. 62,0 %

Std Dev

3 years 16,23
since launch (14.6.2018) 16,23

Sharpe

3 years 1,13
Launch 1,13

Fees

TER 2,00 %
Subscription fee 0,00 %
Redemption fee 1,00 %
Total client relationship allow for changes in tariff rate.
30.06.2021

Our Funds